| Literature DB >> 31451110 |
Anirudh Sharma1, Joydeep Das2.
Abstract
Carbon dots (CDs) are the new fellow of carbon family having a size less than 10 nm and attracted much attention of researchers since the last decade because of their unique characteristics, such as inexpensive and facile synthesis methods, easy surface modification, excellent photoluminescence, outstanding water solubility, and low toxicity. Due to these unique characteristics, CDs have been extensively applied in different kind of scientific disciplines. For example in the photocatalytic reactions, drug-gene delivery system, in vitro and in vivo bioimaging, chemical and biological sensing as well as photodynamic and photothermal therapies. Mainly two types of methods are available in the literature to synthesize CDs: the top-down approach, which refers to breaking down a more massive carbon structure into nanoscale particles; the bottom-up approach, which refers to the synthesis of CDs from smaller carbon units (small organic molecules). Many review articles are available in the literature regarding the synthesis and applications of CDs. However, there is no such review article describing the synthesis and complete application of CDs derived from small organic molecules together. In this review, we have summarized the progress of research on CDs regarding its synthesis from small organic molecules (bottom-up approach) via hydrothermal/solvothermal treatment, microwave irradiation, ultrasonic treatment, and thermal decomposition techniques as well as applications in the field of bioimaging, drug/gene delivery system, fluorescence-based sensing, photocatalytic reactions, photo-dynamic therapy (PDT) and photo-thermal (PTT) therapy based on the available literature. Finally, the challenges and future direction of CDs are discussed.Entities:
Keywords: Biomedical applications; Carbon dots; Hydrothermal/microwave synthesis; Photocatalysis; Sensing
Year: 2019 PMID: 31451110 PMCID: PMC6709552 DOI: 10.1186/s12951-019-0525-8
Source DB: PubMed Journal: J Nanobiotechnology ISSN: 1477-3155 Impact factor: 10.435
Fig. 1General synthesis methods of CDs. Bottom up approach: CDs are synthesized from smaller carbon units (small organic molecules) via applying energy (electrochemical/chemical, thermal, laser, etc.). The source molecules are getting ionized, dissociated, evaporated or sublimated and then condensed to form CDs. Top down approach: CDs are synthesized by transformation of larger carbon structures into ultra-small fragments via applying energy (thermal, mechanical, chemical, ultrasonic, etc.)
Synthesis of CDs from small organic molecules via a top-down approach
| S. No. | Source | Method of preparation | Doping (d)/surface passivating (p) agent | Color | Size (nm) | Refs. No. |
|---|---|---|---|---|---|---|
| 1. | Carbon nanotube | Electrochemical synthesis | – | Blue | 2.8 ± 0.5 | [ |
| 2. | Carbon soot | Chemical oxidation | – | Green | 2–6 | [ |
| 3. | Carbohydrates | Chemical oxidation | (TTDDA) 4,7,10-trioxa-1,13-tridecanediamine (P) | Red, blue, green and yellow | 5 | [ |
| 4. | Low-molecular-weight alcohols | Electrochemical synthesis | – | Red and blue | 2.1, 2.9, 3.5, and 4.3 | [ |
| 5. | Sodium citrate and urea. | Electrochemical synthesis | – | Blue | 1.0–3.5 | [ |
| 6. | Graphite electrode | Electrochemical synthesis | – | Bright yellow | 4 ± 0.2 | [ |
| 7. | Toluene | Laser ablation | – | Red, black and blue | 2–3.9, 3–10.0, 10–17.2 and 13–20.5 | [ |
| 8. | Graphite powders | Laser ablation | – | Red, black and blue | 1.5, 1.6, and 1.8 | [ |
| 9. | Ascorbic acid and ammonia | Ultrasonic treatment | N (d) | Blue, green | 3.36 | [ |
| 10. | Oligomer polyamide resin | Ultrasonic treatment | Silane coupling agent (p) | Bright white | 2–4 | [ |
Synthesis of CDs from small organic molecules via hydrothermal treatment
| S. No. | Source | Method of preparation | Doping (d)/surface passivating (p) agent | Color | Size (nm) | Refs. No. |
|---|---|---|---|---|---|---|
| 1. | Hydrothermal treatment | – | Violet | 2 | [ | |
| 2. | Glucosamine HCl | Hydrothermal treatment | Glucosamine HCl (d) | Green | 15–70 | [ |
| 3. | Glucose, monopotassium phosphate | Hydrothermal treatment | – | Violet | 1.83–3.83 | [ |
| 4. | Dopamine | Hydrothermal treatment | – | Blue, yellow, green | 3.8 | [ |
| 5. | Sodium citrate | Hydrothermal treatment | – | Blue | 1.59 | [ |
| 6. | Citric acid and ethylene diamine | Hydrothermal treatment | – | Blue | 2–6 | [ |
| 7. | bPEI, ammonium persulfate | Hydrothermal synthesis | bPEI | Blue | 3–4 | [ |
| 8. | Streptomycin | Hydrothermal treatment | – | Violet | 2.97 | [ |
| 9. | Histidine, NaOH | Hydrothermal treatment | – | Blue | 3–5 | [ |
| 10. | Ammonium citrate, ethylenediamine | Hydrothermal treatment | N (d) | Blue | 4.8 | [ |
| 11. | Hydrothermal treatment | N, S (d) | Orange | 2.6 | [ | |
| 12. | 1-Octadecane 1-hexadecylamine, citric acid | Hydrothermal synthesis | Dihydrolipoic acid (p) | Yellow | 6–8 | [ |
| 13. | Citric acid | Hydrothermal treatment | Isoleucine (d) | Violet | 6–15 | [ |
| 14. | Ammonium citrate | Hydrothermal treatment | Ethylene diamine (d) | Indigo | 4.8 | [ |
| 15. | Citric acid, ethanediamine | Hydrothermal method | – | Violet | < 5 | [ |
| 16. | Hydrothermal treatment | N, S (d) | Orange | 2.6 | [ | |
| 17. | Citric acid, GSH | Hydrothermal treatment | – | Blue | 2.5–3 | [ |
| 18. | 1-Octadecane 1-hexadecylamine, citric acid | Hydrothermal synthesis | Dihydrolipoic acid (p) | Yellow | 6–8 | [ |
| 19. | Citric acid, NaOH | Hydrothermal treatment | – | Green | 11.3 | [ |
| 20. | Citric acid, NH3·H2O | Hydrothermal treatment | N (d) | Blue | 2 | [ |
| 21. | Folic acid, phosphoric acid | Hydrothermal treatment | Folic acid, phosphoric acid (d) | Indigo | 13.2 ± 1.6 | [ |
| 22. | Glucose | Hydrothermal treatment | – | Blue | 1.65 | [ |
| 23. | Sodium nitrate, histidine | Hydrothermal treatment | – | Indigo | 1.5 | [ |
| 24. | Hydrothermal carbonization | – | Violet | 2.8 | [ | |
| 25. | Folic acid, phosphoric acid | Hydrothermal treatment | Folic acid, phosphoric acid (d) | Indigo | 13.2 ± 1.6 | [ |
| 26. | APTS (3-Aminopropyl)triethoxysilane), Glycerol | Hydrothermal synthesis | – | Violet | 9 ± 0.5 | [ |
| 27. | Citric acid, PEI (polyethyleneimine) | Hydrothermal treatment | – | Blue | 4.5 | [ |
Synthesis of CDs from small organic molecules via microwave treatment
| S. No. | Source | Method of preparation | Doping (d)/surface passivating (p) agent | Color | Size (nm) | Refs. No. |
|---|---|---|---|---|---|---|
| 1. | Saccharides and polyethylene glycol | Microwave synthesis | – | Blue | 3.7 | [ |
| 2. | Citric acid | Microwave synthesis | Tryptophan (d) | Indigo | 2.6 | [ |
| 3. | Glycerol | Microwave synthesis | TTDA (p) | Blue, turquoise, green, jacinth and red | 5 | [ |
| 4. | Carbohydrates and inorganic salts | Microwave synthesis | – | Blue, green, yellow, red | 2.1 | [ |
| 5. | Citric acid | Microwave synthesis | Tryptophan (d) | Indigo | 2.6 | [ |
| 6. | Citric acid | Microwave synthesis | RNase A (d) | Blue | 25–45 | [ |
| 7. | Citric acid, urea | Microwave synthesis | Boric acid, (d) | Indigo | 2–6 | [ |
| 8. | Citric acid | Microwave synthesis | 3-Aminophenyl boronic acid (p) | Indigo | 2–5 | [ |
| 9. | Citric acid, urea | Microwave-assisted synthesis | – | Green | 2–6 | [ |
| 10. | Triammonium citrate | Microwave irradiation | – | Indigo | 6.5 | [ |
| 11. | Glycerol | Microwave pyrolysis | PEI (d, p) | Blue | 9 ± 1.1 | [ |
| 12. | Arginine and glucose | Microwave synthesis | – | Blue | 1–7 | [ |
Synthesis of CDs from small organic molecules via thermal decomposition, carbonization, pyrolysis, solvothermal, and ultrasonic treatment
| S. No. | Source | Method of preparation | Doping (d)/surface passivating (p) agent | Color | Size (nm) | Refs. No. |
|---|---|---|---|---|---|---|
| 1. | Citric acid, | Thermal decomposition | AEAPMS (P) | Blue | 0.9 | [ |
| 2. | Citric acid | Thermal decomposition | DETA (p) | Blue | 3–5.5 | [ |
| 3. | Citric acid | Thermal decomposition | Ruthenium (III) | Blue | 6.8 ± 2.3 | [ |
| 4. | Citric acid | Thermal decomposition | – | Blue | 0.7–1.0 | [ |
| 5. | Thermal decomposition | 1-butyl 3-methyl imidazolium bromide | Blue, yellow, red, green | 1.0–3.5 | [ | |
| 6. | Citric acid | Thermal treatment | Dicyanamide (d) | Green | 8–16 | [ |
| 7. | Glucose | Carbonization | Ethylene diamine (d), phosphoric acid (p) | Green | 1–7 | [ |
| 8. | Citric acid | Carbonization | – | Blue | 4.8–9 | [ |
| 9. | 6- | Carbonization | – | Green | 2.4 ± 0.5 | [ |
| 10. | Tris base, betaine Hcl | Pyrolysis | Gadopetetic acid (d) | Purple, Green | 3.2 | [ |
| 11. | GDs | Pyrolysis | Blue, green and red | 4.66–1.24 | [ | |
| 12. | Pyrolysis | Yellow | 2.28 ± 0.42 | [ | ||
| 13. | Sodium alginate | Pyrolysis | – | Blue | < 10 | [ |
| 14. | Citric acid | Pyrolysis | Diethylenetriamine (p) | Indigo | 5–8 | [ |
| 15. | CCl4, NaNH2 | Solvothermal method | N (d) | Blue, cyan, kelly, and yellow | 3.3 | [ |
| 16. | SiCl4, hydroquinone | Solvothermal treatment | Si (d) | Blue | 7 ± 2 | [ |
| 17. | hydroquinone | Solvothermal method | BBr3 (d) | Blue | 16 | [ |
| 18. | Glucose, HCl/NaOH | Ultrasonic treatment | – | Blue | < 5 | [ |
| 19. | Active carbon, H2O2 | Ultrasonic treatment | – | Blue, green, yellow, red | 5–10 | [ |
Fig. 2General mechanism of image guided drug delivery via CDs: drug loaded CDs enter into the cells, and deliver the drug to nucleus. Also, the intrinsic multicolor fluorescence nature of CDs helps in tracking the drug delivery pathway, and cellular imaging
Role of CDs in bioimaging application
| S. No. | Source molecule | Color | Application (bio-imaging) | Refs. No. |
|---|---|---|---|---|
| 1. | Carbon soot | Blue–yellow | HepG2 cell | [ |
| 2. | Activated carbon | Blue/yellow/green | COS-7 cells | [ |
| 3. | Graphene oxide and DMF | Green | MG-63 cell | [ |
| 4. | Citric acid, AEAPMS and silica | Blue | BGC823 cell | [ |
| 5. | Glucose, monopotassium phosphate | Green | HepG2 cell | [ |
| 6. | Carbon fibers | Green | T47D Cell | [ |
| 7. | Carbon nanotubes and graphite | Yellow | In vivo NIR fluorescence imaging in mice | [ |
| 8. | Graphite rods and hydrazine | Yellow | Neurospheres cells, pancreas progenitor cells, and cardiac progenitor cells were performed | [ |
| 9. | CX-72 carbon black | Green | MCF-7 cell | [ |
| 10. | Glycerol, Polyethylenimine ( | Blue/green/red | COS-7 cell | [ |
| 11. | Glycine | Green | MCF-10A, MCF-7 cells | [ |
| 12. | Glucose and TTDDA | Green | HeLa, MCF-7, NIH-3T3 cells | [ |
| 13. | Glycerol solvent | Blue | HeLa cell | [ |
| 14. | Graphene oxide and ammonia | Green | HELA cell | [ |
| 15. | Citric acid and ethylenediamine | Blue | MC3T3 cell | [ |
| 16. | Sucrose and oil acid | Green | 16HBE cell | [ |
| 17. | Graphene oxide and ammonia | Blue | HeLa cell | [ |
| 18. | Graphene oxide and Dimethylformamide | Green | HeLa cell | [ |
| 19. | Polycyclic aromatic hydrocarbon | Green | MCF-7 cell | [ |
| 20. | Graphite powder | Green/blue | A549 cell | [ |
| 21. | Folic acid | Blue, Green | U87 glioma cell | [ |
| 22. | Polythiophene phenyl propionic acid | Red | HeLa cell imaging and diagnosis | [ |
| 23. | Citric acid, PEG diamine, and Glycerin | Blue | Cholesterol imaging | [ |
| 24. | Citric acid, phosphoric acid, and ethylene diamine | Red, green | RAW 264.7 cells, PA and FL imaging of mice tumors | [ |
| 25. | Urea, polyethylene glycol (PEG) | Blue | L929 cells | [ |
| 26. | Citric acid, urea and sodium fluoride | Red | Glioma C6 cells | [ |
Role of CDs in drug/gene delivery system
| S. No. | Source molecule | Ligand attached | Drug/gene delivery | Cell type | Refs. No. |
|---|---|---|---|---|---|
| 1. | EDTA | Mesoporous silica nanoparticles (MSPs) | DOX | HeLa | [ |
| 2. | Sorbitol and sodium hydroxide | Folic acid | DOX | HeLa | [ |
| 3. | β-Cyclodextrin (βCD), oligoethylenimine (OEI) and Phosphoric acid | OEI/CD | DOX | H1299 | [ |
| 4. | citric acid and | – | DOX | HeLa, mouse fibroblast cells (L929) | [ |
| 5. | Carbon nanopowder | Transferrin | DOX | Glioblastoma cells; CHLA-266, DAOY, CHLA-200 and SJGBM2 cells | [ |
| 6. | Urea and citric acid | carboxyl groups on CDs | DOX | HepG2 and HL-7702 | [ |
| 7. | ATP (Adenosine Triphosphate) moreover, polyethyleneimine (PEI) | Hyaluronic acid (HA) | DOX | HeLa cells | [ |
| 8. | Polydopamine coated | DOX | HeLa | [ | |
| 9. | Citric acid and polyene polyamine (PEPA) | Oxaliplatin | Hepatic cancer cells | [ | |
| 10. | Citric acid and ethylenediamine | – | DOX | L929, MCF-7 and CCK-8 | [ |
| 11. | Citric acid and diethylenetriamine | PEG-(PAH/DMM) | Cisplatin | A2780 | [ |
| 12. | Glycerol and polyethylenimine (PEI) | fc-rPEI (folate conjugated reducible PEI rPEI) | siRNA | H460 | [ |
| 13. | Citric acid and tryptophan | PEI | siRNA | MGC-803 | [ |
| 14. | Branched polyethyleneimine, Hyaluronic acid | Hyaluronate (HA) and polyethyleneimine (PEI) functionalized | DNA/RNA | Hela cells | [ |
| 15. | Polyethyleneimine and fluorinated diglycidyl ethers | Fluorine doped | siRNA/DNA | 7702, A549 and HepG2 | [ |
| 16. | Arginine and glucose | – | pSOX-9 | Chondrogenic differentiation of mouse embryonic Fibroblasts | [ |
Fig. 3General mechanisms of gene delivery via CDs: here CDs bind with gene materials via electrostatic interactions, enter into the cells via endocytosis and release the payloads into nucleus
Role of CDs in bio-sensing application
| S. No. | Precursor molecule | Color | Application (bio-sensing) | Refs. No. |
|---|---|---|---|---|
| 1. | Blue, green and red | H2O2 | [ | |
| 2. | SiCl4, hydroquinone | Blue | Fe3+, H2O2, and melamine | [ |
| 3. | BBr3, hydroquinone | Blue | H2O2 and glucose | [ |
| 4. | Dopamine and (3-aminopropyl) triethoxysilane, glycerol | Blue | Ag+ | [ |
| 5. | Oxalic acid (OA) and urea | Blue | Fe3+ and Ag+ | [ |
| 6. | Fullerenes (C60) | Blue | Fe3+ | [ |
| 7. | Lactose and NaOH | Blue | Folic acid | [ |
| 8. | Galactose and | Blue | Galactose | [ |
| 9. | Citric acid, aminoguanidine | Blue | Nitric oxide (NO) | [ |
| 10. | Citric acid and melamine | Blue | Glutathione | [ |
Fig. 4Role of CDs in chemical and bio-sensing via fluorescence quenching: the change in fluorescence intensity of CDs take place via different mechanisms, such as a Conduction band electrons of CDs shifts to low-lying vacant d-orbital of metal ions, b Electron transfer from CB of CDs to CB of metal ions, c Fluorescence resonance energy transfer (FRET), d Inner filter effect
Role of CDs in chemicals sensing application
| S. No. | Precursor molecule | Application (chemical-sensing) | Refs. No. |
|---|---|---|---|
| 1. | Ethylenediaminetetra acetic acid (EDTA) | Hg2+ | [ |
| 2. | Sodium citrate and citric acid | Hg2+ | [ |
| 3. | Ammonium citrate and ethylenediamine | Hg2+ | [ |
| 4. | Citric acid, NH3·H2O | Hg2+ | [ |
| 5. | Sodium citrate and citric acid | Hg2+ | [ |
| 6. | Phenolphthalein and ethylenediamine | Hg2+, lemon yellow dye, Fe2+ and H2O2 | [ |
| 7. | Citric acid and triethylamine | Hg2+ | [ |
| 8. | pH, Hg2+, Cl− and Cr4+ | [ | |
| 9. | Graphite rods | Fe3+ | [ |
| 10. | Polycyclic aromatic hydrocarbon (PAH) | Fe3+ | [ |
| 11. | Ethylene glycol | Fe3+ | [ |
| 12. | Citric acid | Fe3+ | [ |
| 13. | Citric, thiourea | Fe3+ | [ |
| 14. | Cetylpyridinium bromide (CPB) | Fe2+ | [ |
| 15. | Folic acid and 3-aminopropyl trimethoxy silane | Fe3+ | [ |
| 16. | Phenylenediamine | Fe3+ | [ |
| 17. | Citric acid | Fe3+ and I− | [ |
| 18. | Fe3+ | [ | |
| 19. | CCl4 as a carbon and diamines as nitrogen precursors | Ag+ | [ |
| 20. | Uric acid | Ag+ and Hg2+ | [ |
| 21. | 1,2-diaminobenzene | Ag+ | [ |
| 22. | Citric acid and amino acid | Ag+ | [ |
| 23. | uric acids | Ag+ | [ |
| 24. | Citric acid and guanidine thiocyanate | Ag+ | [ |
| 25. | Urea, polyethylene glycol (PEG) | Ag+ | [ |
| 26. | Citric acid, poly(ethylenimine) for BPEI-CQDs | Cu2+ | [ |
| 27. | Ammonium citrate and ethylenediamine | I− | [ |
| 28. | Sodium alginate | Ascorbic acid | [ |
| 29. | Ascorbic acid and glycol | Al3+ and F− | [ |
| 30. | Citric acid | Selenite (SeO32−) | [ |
| 31. | Citric acid, and 1,6-diaminohexane dihydrochloride | Cr6+ | [ |
Role of in CDs in photocatalytic application
| S. No. | Nanomaterial | Source molecules | Photocatalysis application/role of support | Refs. No. |
|---|---|---|---|---|
| 1. | S, N doped GDs/TiO2 | Citric acid for c-dots and urea/thiourea for N, S | Degradation of Rhodamine B | [ |
| 2. | CDs/Ag/Ag2O | Glucose | Rhodamine b | [ |
| 3. | CDs/g-C3N4 | Citric acid, ethylenediamine | Degradation of Rhodamine B and tetracycline hydrochloride (TC-HCl) | [ |
| 4. | S, N doped GDs/g-C3N4 | Citric acid and thiourea | Rhodamine B (RhB) degradation | [ |
| 5. | CDs/Bi2O3 | degradation of Rhodamine b | [ | |
| 6. | Ultrafine amorphous iron oxyhydroxide/ultrathin g-C3N4 | Urea | Degradation of Rhodamine B, methylene blue, and methyl orange | [ |
| 7. | CDs/La2Ti2O7 | Vitamin C and ethanol | Rhodamine B (RhB) | [ |
| 8. | Reduced graphene oxide/ZnO | Graphite oxide | CO2 photoreduction | [ |
| 9. | g-C3N4 | Urea or melamine | Conversion of CO2 into methanol | [ |
| 10. | Au-doped CDs | Carbon-based | CO2 Photoreduction | [ |
| 11. | PEG1500N-functionalized CDs with Au/Pt doping | Carbon-based | H2 generation, and CO2 photoreduction | [ |
| 12. | CDs/TiO2 | Graphite | H2 generation | [ |
| 13. | CDs/TiO2 | Vitamin C | H2 generation | [ |
| 14. | CDs | Citric acid | H2 generation | [ |
| 15. | N doped GDs-ZnNb2O6/g-C3N4 heterostructures | Urea for g-C3N4 and C6H5O7(NH4)3, NaOH for NGDs | H2 generation | [ |
| 16. | CDs/nitrogen-doped ZnO | Carbon black pigment | Methylene blue | [ |
| 17. | N doped CDs/TiO2 | Glycerol and TTDDA | Degradation of methylene blue | [ |
| 18. | CDs/Ag/Ag2O | Glucose | Degradation of methylene blue | [ |
| 19. | Ultrafine amorphous iron oxyhydroxide/ultrathin g-C3N4 nanosheets | Urea | Methylene blue, and methyl orange | [ |
| 20. | Fe(III)/CDs | Oxidative coupling of Xylene by anhydrous FeCl3 | H2O2 reduction | [ |
| 21. | CDs/nitrogen-doped ZnO | Carbon black pigment | Degradation of malachite green | [ |
| 22. | La/Cu/Zr/CDs | Degradation of ampicillin antibiotic, malachite green | [ | |
| 23. | N doped CDs | Glucose and ammonia | Photodegradation of methyl orange | [ |
| 24. | Ultrafine amorphous iron oxyhydroxide/ultrathin g-C3N4 nanosheets | Urea | Methyl orange | [ |
| 25. | CDs/Bi2WO6 | Citric acid, ethylenediamine | Degradation of methyl orange and bisphenol A | [ |
| 26. | CDs/ZnFe2O4 | L-Ascorbic acid,, glycol, and deionized water | NO removal | [ |
| 27. | Pb–CDs–TiO2 | Ascorbic acid and kollicoat | Degradation of RBX, CRB, and CNB dye | [ |
| 28. | Ag-CDs/g-C3N4 | Citric acid, ethylenediamine | Naproxcen | [ |
| 29. | CDs/g-C3N4/MoO3 | Citric acid, urea and dicyandiamide | Degradation of tetracycline (TC) | [ |
Fig. 5Role of CDs in photocatalytic applications: CDs help in photocatalysis via different mechanisms, such as a up conversion photoluminescence of CDs, b action of CDs as electron reservoir, c action of CDs as sensitizer. Furthermore, the π–π stacking between CDs and organic dye also enhances its degradation upon light irradiation
Role of CDs in photo-dynamic therapy (PDT) and photo-thermal (PTT) therapy
| S. No. | Source molecule | Ligand attached | Targeted cell type | Refs. No. |
|---|---|---|---|---|
| 1. | Polythiophene phenylpropionic acid | – | Hela cells | [ |
| 2. | Diaminohexane and carboxylic group of Ce6 | Ce6-HA (hyaluronate) | B16F10 melanoma | [ |
| 3. | Acrylic acid, 1, 2-ethylenediamine (EDA) and Mg(OH)2 | Mg/N | HepG2 | [ |
| 4. | Hydrophobic cyanine dye and poly(ethylene glycol) | – | HepG2, CT26 | [ |
| 5. | Citric acid and urea | – | HeLa | [ |
| 6. | Dopamine | – | Hela cells | [ |
| 7. | Urea | Carbon nitride (C3N4) | 4T1 | [ |
| 8. | Citric acid and 5,10,15,20-tetrakis(4-aminophenyl)porphyrin | Cetuximab (C225) | HCC827 and MDA-MB-231 cells | [ |
| 9. | Protoporphyrin IX (PpIX) | HeLa | [ | |
| 10. | EDTA·2Na and CuCl2 | – | Murine melanoma (B16) cells | [ |
Fig. 6Role of CDs in Photo thermal (PTT) and Photo dynamic (PDT) therapy. PTT: after the cellular internalization of CDs, laser light irradiation (mostly near infrared) is used which is absorbed by the CDs to generate local heat and destroy diseased tissue. PDT: CDs carry a photosensitizer into the cellular system. Upon laser light irradiation, free radicals/reactive oxygen species are generated, leading to cancer cell death